We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$13.9B
AUM Growth
+$1.1B
Cap. Flow
+$429M
Cap. Flow %
3.1%
Top 10 Hldgs %
15.18%
Holding
2,493
New
259
Increased
931
Reduced
887
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 11.22%
2 Healthcare 9.72%
3 Financials 9.67%
4 Industrials 7.05%
5 Consumer Discretionary 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNCA
2101
DELISTED
Genocea Biosciences, Inc.
GNCA
$64K ﹤0.01%
10,263
+4,000
+64% +$21.1K
OMC icon
2102
PUT
Omnicom Group
OMC
$22.7B
$63K ﹤0.01%
30,000
-10,000
-25% -$701K
SENS icon
2103
Senseonics Holdings Inc
SENS
$254M
$63K ﹤0.01%
650
-75
-10% -$6.14K
HSTO
2104
DELISTED
Histogen Inc. Common Stock
HSTO
$63K ﹤0.01%
+55
New +$50.7K
SBSW icon
2105
Sibanye-Stillwater
SBSW
$5.92B
$61K ﹤0.01%
24,558
GALT icon
2106
Galectin Therapeutics
GALT
$229M
$60K ﹤0.01%
+9,905
New +$54.5K
SRGA
2107
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$59K ﹤0.01%
431
+31
+8% +$4.27K
QQQ icon
2108
PUT
Invesco QQQ Trust
QQQ
$455B
$58K ﹤0.01%
38,400
-57,900
-60% -$10.5M
ATAXZ
2109
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$58K ﹤0.01%
10,000
NG icon
2110
NovaGold Resources
NG
$2.6B
$57K ﹤0.01%
15,238
+1,000
+7% +$4.03K
HTGM
2111
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$57K ﹤0.01%
+63
New +$41.6K
AGEN
2112
Agenus
AGEN
$249M
$56K ﹤0.01%
1,330
+158
+13% +$6.22K
LTRX icon
2113
Lantronix
LTRX
$236M
$56K ﹤0.01%
+13,850
New +$53.4K
VANI icon
2114
Vivani Medical
VANI
$110M
$55K ﹤0.01%
+1,217
New +$49.1K
META icon
2115
PUT
Meta Platforms (Facebook)
META
$1.51T
$54K ﹤0.01%
4,400
+1,700
+63% +$308K
NM
2116
DELISTED
Navios Maritime Holdings Inc.
NM
$54K ﹤0.01%
7,626
CSX icon
2117
CALL
CSX Corp
CSX
$98.6B
$53K ﹤0.01%
+56,400
New +$1.34M
STGW icon
2118
Stagwell
STGW
$1.84B
$53K ﹤0.01%
12,678
ACHN
2119
DELISTED
Achillion Pharmaceuticals
ACHN
$53K ﹤0.01%
14,498
+100
+0.7% +$298
SCU
2120
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$51K ﹤0.01%
3,478
+16
+0.5% +$303
FBIO icon
2121
Fortress Biotech
FBIO
$111M
$50K ﹤0.01%
+2,073
New +$66.3K
BCIC
2122
BCP Investment Corp
BCIC
$86.9M
$50K ﹤0.01%
1,503
AVP
2123
DELISTED
Avon Products, Inc.
AVP
$50K ﹤0.01%
+23,028
New +$42.4K
PARA
2124
CALL
DELISTED
Paramount Global Class B
PARA
$49K ﹤0.01%
+18,000
New +$994K
CPRX
2125
DELISTED
Catalyst Pharmaceutical
CPRX
$47K ﹤0.01%
12,411

Similar funds

HighTower Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, HighTower Advisors held 2,493 positions worth $13.9B, up 8.6% from $12.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

HighTower Advisors deployed $429M of net new capital in Q3 2018, opening 259 new positions and adding to 931 existing holdings. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 327,271 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $13.9M trimmed.

  • HighTower Advisors's largest Q3 2018 buy was State Street SPDR S&P Pharmaceuticals ETF: 327,271 shares worth $15.9M.
  • HighTower Advisors added most to Invesco QQQ Trust in Q3 2018, an estimated $91.7M increase.
  • HighTower Advisors's biggest Q3 2018 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $13.9M.
  • HighTower Advisors fully exited abrdn Physical Gold Shares ETF in Q3 2018, selling an estimated $13.4M.
  • HighTower Advisors's ten largest holdings make up 15% of its $13.9B portfolio in Q3 2018.
  • HighTower Advisors opened 259 new positions and closed 213 in Q3 2018.
  • HighTower Advisors's portfolio value rose 8.6% quarter-over-quarter to $13.9B.

Based on HighTower Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.